Optimization of Cardiac Resynchronization Therapy by Non-Invasive Imaging of Cardiac Electrophysiology

ConditionHeart Failure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMedical University Innsbruck

About this trial

The principal aim is to analyze total left and right ventricular activation time in different CRT device programming algorithms (SyncAV) measured by non-invasive electrophysiology

Eligibility criteria

Qualifiers

patients after successful implantation of a CRT-D or CRT-P device in whom a cardiac magnetic resonance examination is possible and the device is equipped with the SyncAV® programming software

left bundle branch block before CRT implantation

PQ interval ≤ 250 ms before implantation

Disqualifiers

high-grade AV block

any contraindication concerning a safe CMR performance including claustrophobia

terminal heart failure (NYHA IV) or cardiac decompensation

life expectancy < 1 year

Trial design

Treatments tested in this trial

  • Device programming

Treatment groups

25 Participants
are divided into 1 treatment group

Sponsors and collaborators